EUVIMEDEUVIMED entdecken
Crossref

Desmoid tumour Treatment Outcome: A single institution experience

Mohamed Hegazy

Biomedical and Clinical Research · 2022

DOI: 10.31579/2834-8486/003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical and Clinical Research, 2022. Verfasst von Mohamed Hegazy.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Desmoid tumour (DT) is a rare locally aggressive disease with tendency for local recurrence and the peak incidence age of 30-40 years. DT prognostic factors are still conflicting like surgical margin, disease location, age and gender. The various treatment options including surgery, radiotherapy and systemic agents are generally offered according to the disease presenting symptoms and progressiveness.

Zitieren

APA

Hegazy, M. (2022). Desmoid tumour Treatment Outcome: A single institution experience. Biomedical and Clinical Research. https://doi.org/10.31579/2834-8486/003

Vancouver

Hegazy M. Desmoid tumour Treatment Outcome: A single institution experience. Biomedical and Clinical Research. 2022. doi:10.31579/2834-8486/003

BibTeX
@article{Hegazy2022,
  author = {Hegazy, Mohamed},
  title = {Desmoid tumour Treatment Outcome: A single institution experience},
  journal = {Biomedical and Clinical Research},
  year = {2022},
  doi = {10.31579/2834-8486/003}
}
Kostenlos starten →